Pietro Andreone

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" (2005)

Bihl, Florian K, Loggi, Elisabetta, Chisholm, John V, Hewitt, Hannah S, Henry, Leah M, Linde, Caitlyn, ...

Abstract The assessment of cellular anti-viral immunity is often hampered by the limited availability of adequate samples, especially when attempting simultaneous, high-resolution determination of T...

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e Antigen–negative patients receiving lamivudine therapy (2000)

Lok, Anna Suk-Fong, Hussain, Munira, Cursano, Carmela, Margotti, Marzia, Gramenzi, Annagiulia, Luca Grazi, Gian, ...

Lamivudine has been shown to be effective in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B, but its long-term efficacy and the rate of resistant mutations in patients with...

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

Bihl, Florian K, Loggi, Elisabetta, Chisholm, John V, Hewitt, Hannah S, Henry, Leah M, Linde, Caitlyn, ...

The assessment of cellular anti-viral immunity is often hampered by the limited availability of adequate samples, especially when attempting simultaneous, high-resolution determination of T cell...

Sensitive Line Probe Assay That Simultaneously Detects Mutations Conveying Resistance to Lamivudine and Adefovir

Hussain, Munira, Fung, Scott, Libbrecht, Evelien, Sablon, Erwin, Cursaro, Carmela, Andreone, Pietro, ...

The INNO-LiPA HBV DR v2 assay is designed to detect hepatitis B virus mutations conveying resistance to lamivudine and adefovir. Our study confirms that this assay can simultaneously detect the...

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

Bihl, Florian K, Loggi, Elisabetta, Chisholm, John V, Hewitt, Hannah S, Henry, Leah M, Linde, Caitlyn, ...

The assessment of cellular anti-viral immunity is often hampered by the limited availability of adequate samples, especially when attempting simultaneous, high-resolution determination of T cell...

Sensitive Line Probe Assay That Simultaneously Detects Mutations Conveying Resistance to Lamivudine and Adefovir

Hussain, Munira, Fung, Scott, Libbrecht, Evelien, Sablon, Erwin, Cursaro, Carmela, Andreone, Pietro, ...

The INNO-LiPA HBV DR v2 assay is designed to detect hepatitis B virus mutations conveying resistance to lamivudine and adefovir. Our study confirms that this assay can simultaneously detect the...

Hepatitis B Virus e Antigen Loss during Adefovir Dipivoxil Therapy Is Associated with Enhanced Virus-Specific CD4+ T-Cell Reactivity▿

Cooksley, Helen, Chokshi, Shilpa, Maayan, Yafit, Wedemeyer, Heiner, Andreone, Pietro, Gilson, Richard, ...

Weak T-cell reactivity to hepatitis B virus (HBV) is thought to be the dominant cause for chronic HBV infection. Treatment with adefovir dipivoxil (ADV) increases the rate of HBV e antigen (HBeAg)...

Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire ▿ †

Tan, Anthony Tanoto, Loggi, Elisabetta, Boni, Carolina, Chia, Adeline, Gehring, Adam J., Sastry, Konduru S. R., ...

Repertoire composition, quantity, and qualitative functional ability are the parameters that define virus-specific T-cell responses and are linked with their potential to control infection. We took...

Stem cells for end stage liver disease: How far have we got?

Lorenzini, Stefania, Gitto, Stefano, Grandini, Elena, Andreone, Pietro, Bernardi, Mauro

End stage liver disease (ESLD) is a health problem worldwide. Liver transplantation is currently the only effective therapy, but its many drawbacks include a shortage of donors, operative damage,...